Form 4: Guardant Health Executive AmirAli Talasaz Reports Stock Transactions
SEC Form 4 Filing
Co-Chief Executive Officer AmirAli Talasaz reports the disposition and acquisition of Guardant Health, Inc. stock related to the vesting of restricted stock units.
Summary
- On March 14, 2025, AmirAli Talasaz, Co-Chief Executive Officer of Guardant Health, Inc., reported transactions involving the company's common stock.
- Talasaz disposed of 34,853 shares at a price of $42.89 to cover tax withholding obligations related to the vesting of restricted stock units.
- Additionally, 68,769 shares were acquired upon the vesting of performance-based restricted stock units.
- Following these transactions, Talasaz directly owns 2,295,247 shares of Guardant Health, Inc.
- The transactions were related to the vesting of performance-based restricted stock units.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing detailing stock transactions. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.
Industry Context
This filing is a routine disclosure related to executive compensation and stock ownership, common in publicly traded companies. It provides transparency into the transactions of company insiders.
Key Dates
| Date | Description |
|---|---|
| 03/14/2025 | Date of stock transactions (acquisition and disposition) and vesting of performance-based restricted stock units. |
| 03/18/2025 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.